Harrow Health, Inc.HROWNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank71
3Y CAGR+15.2%
5Y CAGR+12.5%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+15.2%/yr
vs +10.2%/yr prior
5Y CAGR
+12.5%/yr
Consistent
Acceleration
+5.0pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.27 | +5.4% |
| 2024 | 6.90 | +86.5% |
| 2023 | 3.70 | -22.2% |
| 2022 | 4.76 | +29.1% |
| 2021 | 3.68 | -8.7% |
| 2020 | 4.03 | -3.3% |
| 2019 | 4.17 | +29.3% |
| 2018 | 3.22 | +90.6% |
| 2017 | 1.69 | -8.1% |
| 2016 | 1.84 | - |